Peptide
Benralizumab
Benralizumab is used or studied for eosinophil depletion and related immune, inflamation and longevity goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Detail
Overview
Benralizumab is used or studied for eosinophil depletion and related immune, inflamation and longevity goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Benefits, side effects, and protocols
Benefits list
- Eosinophil depletion
Side effects
- Headache
- fever
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- High
- Asthma biologic
Regulatory
- Fda Approved
- Prescription required
Research
Mechanisms
Evidence notes
- High
- Asthma biologic
Administration
Contraindications
- None listed
Components
- None listed
Regulatory data
- Fda Approved
- Prescription required
Aliases
- None listed
Related compounds
Half-life
How long does Benralizumab stay in your system?
Half-life ≈ 15.5 days — see what remains after any number of days, and when it is practically cleared.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Benralizumab? Check your source before you use anything.